These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5536780)

  • 21. The effect of amantadine on radiolabeled biogenic amines in the rat brain.
    Symchowicz S; Korduba CA; Veals J
    Eur J Pharmacol; 1973 Feb; 21(2):155-60. PubMed ID: 4696098
    [No Abstract]   [Full Text] [Related]  

  • 22. [Adrenaline, noradrenaline, dopamine and DOPA in the blood and other tissues of white rats following cranio-cerebral injury].
    Matlina ESh; Rakhmanova TB
    Biull Eksp Biol Med; 1967 Mar; 63(3):55-7. PubMed ID: 5622344
    [No Abstract]   [Full Text] [Related]  

  • 23. Demethylation of L-3-methoxytyrosine in vivo.
    Bartholini G; Pletscher A
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 274(4):404-9. PubMed ID: 4263632
    [No Abstract]   [Full Text] [Related]  

  • 24. The synthesis of noradrenaline by isolated guinea-pig atria.
    Merrills RJ; Offerman J
    Biochem J; 1966 Jun; 99(3):538-45. PubMed ID: 5964955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CATECHOLAMINE BIOSYNTHESIS IN VIVO: AN APPLICATION OF THIN-LAYER CHROMATOGRAPHY.
    SCHNEIDER FH; GILLIS CN
    Biochem Pharmacol; 1965 Apr; 14():623-6. PubMed ID: 14322982
    [No Abstract]   [Full Text] [Related]  

  • 26. Metabolism of dihydroxyphenylalanine and tryptophan in pyridoxine-deficient rats.
    Sourkes TL; Missala K
    Ann N Y Acad Sci; 1969 Sep; 166(1):235-45. PubMed ID: 5262018
    [No Abstract]   [Full Text] [Related]  

  • 27. Enhancement of brain L-dopa concentration with -chymotrypsin.
    Seneca H; Henderson E
    J Am Geriatr Soc; 1973 Jun; 21(6):256-8. PubMed ID: 4710643
    [No Abstract]   [Full Text] [Related]  

  • 28. THE TURNOVER OF ENDOGENOUSLY LABELED CATECHOLAMINE IN SEVERAL REGIONS OF THE SYMPATHETIC NERVOUS SYSTEM.
    BURACK WR; DRASKOCZY PR
    J Pharmacol Exp Ther; 1964 Apr; 144():66-75. PubMed ID: 14191468
    [No Abstract]   [Full Text] [Related]  

  • 29. Application of steady-state kinetics to the study of catecholamine turnover after monoamine oxidase inhibition or reserpine administration.
    Neff NH; Costa E
    J Pharmacol Exp Ther; 1968 Mar; 160(1):40-7. PubMed ID: 5639109
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of L-dopa on accumulation and efflux of monoamines in particles of rat brain homogenates.
    Ng LK; Colburn RW; Kopin IJ
    J Pharmacol Exp Ther; 1972 Nov; 183(2):316-25. PubMed ID: 5083548
    [No Abstract]   [Full Text] [Related]  

  • 31. Depletion of brain noradrenaline and dopamine by 6-hydroxydopamine.
    Breese GR; Traylor TD
    Br J Pharmacol; 1971 May; 42(1):88-99. PubMed ID: 5580702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The mechanism of tissue norepinephrine depletion by alpha, alpha'-dipyridyl.
    Bapna J; Neff NH; Costa E
    Neuropharmacology; 1970 Jul; 9(4):333-40. PubMed ID: 5456579
    [No Abstract]   [Full Text] [Related]  

  • 33. [3H]DOPA formed from [3H]tyrosine in living rat brain is not committed to dopamine synthesis.
    Cumming P; Ase A; Kuwabara H; Gjedde A
    J Cereb Blood Flow Metab; 1998 May; 18(5):491-9. PubMed ID: 9591841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of DOPA on catecholamine metabolism in spinal pain syndrome].
    Matlina ESh; Pukhova GS; Grafova VN; Kassil' GN; Kryshanovskii GN
    Vopr Med Khim; 1973; 19(2):173-6. PubMed ID: 4707507
    [No Abstract]   [Full Text] [Related]  

  • 35. Time-dependent changes in brain 3 H-norepinephrine disappearance caused by L-DOPA administration.
    Hyyppä MT; Wurtman RJ
    Life Sci I; 1972 Aug; 11(15):713-21. PubMed ID: 4678968
    [No Abstract]   [Full Text] [Related]  

  • 36. Regional effects of L-dihydroxyphenylalanine (L-dopa) on norepinephrine metabolism in rat brain.
    Romero JA; Chalmers JP; Cottman K; Lytle LD; Wurtman RJ
    J Pharmacol Exp Ther; 1972 Feb; 180(2):277-85. PubMed ID: 5010674
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibition of DOPA accumulation by rat brain at critical L-DOPA circulating concentrations.
    Horst WD; Bautz G; Renyi E; Spirt N
    Adv Neurol; 1974; 5():369-73. PubMed ID: 4440584
    [No Abstract]   [Full Text] [Related]  

  • 38. 6-hydroxydopamine, 6-hydroxydopa and degeneration of adrenergic nerves.
    de Champlain J; Nadeau R
    Fed Proc; 1971; 30(3):877-85. PubMed ID: 4324975
    [No Abstract]   [Full Text] [Related]  

  • 39. Endogenous dopa in rat brain. Occurrence, distribution and relationship to changes i catecholamine synthesis.
    Thiede HM; Kehr W
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Jul; 316(4):299-303. PubMed ID: 6791035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Catecholamine metabolism in the brains of ageing male mice.
    Finch CE
    Brain Res; 1973 Mar; 52():261-76. PubMed ID: 4700706
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.